Jalyn is dutasteride and tamsulosin.
- TRADE NAMES: Avodart (GSK); Jalyn (GSK)
- INDICATIONS: Benign prostatic hyperplasia; male pattern baldness (anecdotal)
- CLASS: 5-alpha reductase inhibitor, Androgen antagonist
- HALF-LIFE: 3–5 weeks
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Cimetidine, Ciprofloxacin, Conivaptan, Darunavir, Delavirdine, Diltiazem, Indinavir, Ketoconazole, Ritonavir, Telithromycin, Troleandomycin, Verapamil, Voriconazole
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of dutasteride in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 07/31/2023
